Get complete information related to latest Fat Emulsion Tenders . from India at Classic Tenders. Search the best available tenders from Indian government tenders, domestic Fat Emulsion Tenders , private tenders, online tenders, tender invitation notice, business tender notices, online tenders and bidding Fat Emulsion Tenders.
Tender For e-tender for procurement of essential drug items under table-a, for one year from the date of aoc. - aceclofenac tab ip 100mg, albendazole tab. i.p. 400 mg., ambroxol syrup i.p. 30 mg / 5 ml, atorvastatin 40mg tab., drotavarine i.p. 40 mg tab, fluphenazine inj. 25mg, gabapentin tab/cap ip 300 mg, iron & folic acid tabs (wifs-junior). each sugar coated- pink coloured tablet contains: dried ferrous sulphate ip 150mg eq. to elemental iron 45 mg & folic acid ip 0.4 mg, iron & folic acid tabs each sugar coated - permitted edible blue colour tablet contains dried ferous sulphate ip - equivalent to 60 mg (elementary iron) & folic acid ip - 0.5mg (i.e. 500 mcg) as per rule 127 of the drugs and cosmetics rules, 1945, miconazole cream i.p 2%, quinine sulphate tab. i.p. 300 mg, sucralfate oral suspension 1g / 5ml, terbinafine 1% cream, important note: 1. all prospective bidders are requested to quote the rate in boq as per accounting unit & item specification as mentioned in the table-a. wrong quoting of the rate in boq will be dealt with as per penal provisions of the t&c of the tender.2. tendered quantity is just a tentative quantity and should not be treated as final. it may increase or decrease, as per need of the state. keeping this in mind, the supplier is not allowed to seek termination of the rate contract after finishing supply of tendered quantity.3. quality of the product supplied, may be ascertained by testing / physical examination by the experts at any stage of the tender period.4. the prospective bidders of the said tender are requested to make a declaration in affidavit under annexure vi(b) in case of sole manufacturer/importer (i.e. proprietary in nature).5. if the item(s) under sole manufacturer / importer is (are) proprietary in nature, quarterly intimation is solicited from the approved bidders positively regarding the status of their item(s) proprietary in nature, otherwise their item(s) will be blocked in the smis.6. in case of tie bid, decision will be taken by the tia as per g.o. no. 2320-f(y), dated 07.06.2022 issued from finance department audit branch (group t).
Tender For bid to ras corrigendum : supply of iv fluid : : -iv fluid dextrose 100ml bottle , closed system d5 iv infusion 500 ml bottle , closed systemdns iv infusion 500 ml , iv fluid normal saline 100ml , iv fluid normal saline 500ml , closed system ns iv infusion 100 ml , closed system ns iv infusion 500 ml , iv fluid normal saline glass bottle , iv fluid normal saline 0. 9percent 3000ml , plasmalyte solution for infusion 1000ml collapsible container , haemaceal infusion 500ml bottle , iv fluids hes starch 500ml , intravenous fatemulsion for infusion
Tender For corrigendum : empanelment of chemist/wholesale distributors/suppliers for supply of railway board approved source/un approved source for immediate requirement of life saving/essential and other items/drugs and medicines under rate contract on uniform discount rate on mrp for two years to 1. divisional railway hospital/madurai 2. sengottai railway health unit 3. tirunelveli railway health unit 4. tuticorin railway health unit 5. virudhunagar railway health unit 6. dindigul railway health unit 7. palani railway health unit 8. manamadurai railway health unit 9. karaikudi railway health unit 10. mandapam railway health unit[quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 lacs ]
Tender For corrigendum : supply of sch i (supply of injections & sera vaccines) - sch i (supply of injections & sera vaccines), inj. b complex for prophylactic use vit. c 150 mg vit. b 12 2500 mcg folic acid 0.7 mg niacinamide 12 mg, inj. b complex for therapeutic use each ml contain vit a 1000 iu cholecalciferol 100 iu alphatochopherol acetate 0.5 mg. thiamine 5 mg. pyridoxine 0.5 mg. nicotinamide 10 mg. ascorbic acid 50 mg. d-panthenol 2.5 mg., inj. calcium gluconate 10% iv use., inj. desferroxamine 500 mg, inj. digoxin 0.5 mg iv use, inj. diltiazem 5 mg/ml, inj. fluconazole 200 mg. in plastic bottle, inj. fluorescein sodium (20%), inj. hydralazine 20 mg. iv, inj. hyaluronidase 1500 iu, inj. insulin plain (purified human) 40 units/ml sc/iv use (insulin plain and insulin nph/ lente should be of the same manufacturer and their rate will be considered as a unit.), inj.insulin nph/isophane40 iu (highly purified bovine porcine isophane insulin susp 40 i.u./ml nph insulin (or neutral protamine hagedorn)., inj. isoxsuprine hcl 10 mg/ml., intravenous injection of n (2)-l alanyl-l glutamine 20%, solution 50 ml, iv lipid 20% for neo-natal use., inj.lorazepam 2 mg/ml im/iv use., inj. l-ornithine l-aspartate 5 gm, inj. n-butyl cyanoacrylate 0.5 gm., inj. methylene blue 10 mg/ml, inj. metoprolol 5mg, nitroglycerine lingual spray in ready to use formulation. each spray should deliver 0.35 to 0.4 mg/spray 60-70 lit/spray., inj. phenobarbitone sodium 200 mg iv use, inj. protamine sulphate 1% iv use, inj. somatostatin 3 mg /vial, sterile & pyrogen free water for injection i.p 5ml, inj.sterile & pyrogen free water for injections i. p. 10 ml, inj. thiamine 100 mg/ml, inj. tricort triamcinolone sodium 10 mg, inj. tuberculine p. p. d. 5 t. u./0.1 ml intradermal use., inj. vit. k 10 mg/ml (aqueous) i. m./i. v., inj. valethamate bromide 8 mg, inj. benzathine penicillin 6 lacs unit for im use, inj. benzathine penicillin 12 lacs unit im use, inj. benzyl penicillin/ penicillin g/ crystalline penicillin salt 1000000 units/bulbs i. m./i. v., inj. ofloxacin 200 mg, inj. streptomycin sulphate 0.75 gm, inj. anti d 300 microgram/dose polyclonal/monoclonal, inj. diptheria antitoxin 10000 iu, inj. hepatitis b vaccine recombinant dna technology 20 mcg/ml, inj. hib vaccine 10 mcg. haemophilus influenza type b. polysacchride conjugate vaccine. [powder to be reconstituted with 0.5 ml diluent (saline)]., inj. human rabies immunoglobulin 150 i.u./ml, inj meningococcal conjugate vaccine single dose vial containing (a, c, y & w 135) polysaccharide conjugated to diptheria toxoid protein carrier., inj. mmr vaccine (measles, mumps & rubella) single dose im or sc., inj. pneumovax (pneumococcal 23 valent vaccine), inj. polyvalent antisnake venom serum- should contain equivalent of 10 ml of purified globulins 1 ml of reconstituted serum to neutralizes 0.5 mg to 0.6 mg of dried cobra venom, 0.45 mg of dried common krait venom, 0.6 mg. of dried russells viper venom, 0.45 mg of dried saw scaled viper venom, liquid or powder form will be accepted, inj. rabies human monoclonal antibody (rdna) 40 iu/ml., inj. tetanus vaccine purified toxoid adsorbed i. p. 5 lf./0.5ml, inj. tetanus immunoglobulin (human) 250 i. u. im / intrathecal use., inj. tetanus immunoglobulin (human) 500 i. u. im / intrathecal use., inj. lignocaine 10% spray, inj. propofol 1% mct/lct fatemulsion with sodium oleate 50 ml, inj. ropivacaine hcl 0.5%, inj. 2% hydroxypropyl methyl cellulose preservative free sterile for intraocular use during cataract surgery in sterile prefilled syringe & with sterile cannula., intracameral injection lignocaine hydrochloride 1%, inj. perfluoro-n-octane liquid for intraocular use sterile, inj. pilocarpine (0.5%) nitrate/hcl sterile opthalmic solution for injection., inj. silicon oil for (polydimethyl siloxane for intraocular use) sterile viscosity 1500 mm2/s cst, inj. sodium hyaluronate 1.4%, inj. sodium hyaluronate 1.8%, inj. continuous ambulatory peritoneal d
Tender For supply of 2026-27 (ami no. 30.08) 2026-27 (ami no. 30.08) intravenous fatemulsion 20% fat infusion in the power of 250 ml or 500 ml (minimum energy content should be at least 1800kcal/1000ml inpack of 250ml or 500 ml bottle). [quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 lacs ]